{"id":4800,"date":"2014-01-08T13:40:47","date_gmt":"2014-01-08T12:40:47","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=4800"},"modified":"2014-01-08T13:40:47","modified_gmt":"2014-01-08T12:40:47","slug":"queratosis-actinica-una-lesio-premaligna-en-augment","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/","title":{"rendered":"Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment"},"content":{"rendered":"\n<p>\u201cEls usuaris, normalment, quan detecten qualsevol s\u00edmptoma a la pell venen a la farm\u00e0cia a consultar i \u00e9s important estar informat per donar un consell professional\u201d. Aix\u00f2 ho va dir N\u00faria Bosch, vocal de Dermofarm\u00e0cia del Col\u00b7legi, nom\u00e9s comen\u00e7ar la confer\u00e8ncia \u201cQueratosis act\u00ednica, una lesi\u00f3 premaligna\u201d, que va tenir lloc el 4 de desembre.<\/p>\n<p><strong><span style=\"color: #888888;\" data-mce-mark=\"1\">El cicle de confer\u00e8ncies \u201cQ\u00fcesti\u00f3 de pell&#8221; pret\u00e9n revisar i actualitzar els coneixements en dermofarm\u00e0cia dels farmac\u00e8utics davant de les consultes m\u00e9s freq\u00fcents.<\/span><\/strong><\/p>\n<p>La queratosis act\u00ednica, un tumor de la pell que pot derivar en c\u00e0ncer cutani, \u00e9s molt desconeguda per\u00f2 amb gran incid\u00e8ncia entre la poblaci\u00f3. Aquest \u00e9s el principal motiu pel qual el Dr. J. Malvehy, dermat\u00f2leg, director de la Unitat de Melanoma, consultor de dermatologia de l&#8217;Hospital Cl\u00ednic i Provincial de Barcelona i ponent de l\u2019acte, considera que \u00e9s important que els farmac\u00e8utics estiguin preparats per assessorar sobre aquest tema.<\/p>\n<p>L\u2019acte, emmarcat dins el cicle de confer\u00e8ncies \u201cQ\u00fcesti\u00f3 de pell\u201d que acull el Col\u00b7legi, va estar patrocinat per LEO i va abordar temes relacionats amb la prevenci\u00f3 i tractament d&#8217;aquest tipus de lesions. \u201cEl principal causant \u00e9s el sol, i tot i que la gent sap com protegir-se, no es prenen les precaucions pertinents\u201d, va explicar el doctor. Tot i aix\u00ed, tamb\u00e9 influeixen altres elements, com factors gen\u00e8tics, l&#8217;augment de l\u2019esperan\u00e7a de vida o no cuidar correctament la pell.<\/p>\n<p>Alguns dels productes als quals va fer refer\u00e8ncia Malvehy per prevenir aquesta lesi\u00f3 van ser filtres solars en crema i productes de quimioprevenci\u00f3 del c\u00e0ncer de pell. D\u2019altra banda, per tractar-la va destacar la ter\u00e0pia fotodin\u00e0mica i productes aplicats en cremes.<\/p>\n<h6 style=\"text-align: right;\"><span style=\"color: #888888;\">Amb el patrocini de:<\/span><\/h6>\n<p><a href=\"http:\/\/www.leo-pharma.es\/\"><img decoding=\"async\" class=\"alignright  wp-image-4851\" alt=\"LEO\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/01\/LEO.jpg\" width=\"117\" height=\"85\" \/><\/a><\/p>\n<p style=\"text-align: right;\">\n","protected":false},"excerpt":{"rendered":"<p>\u201cEls usuaris, normalment, quan detecten qualsevol s\u00edmptoma a la pell venen a la farm\u00e0cia a consultar i \u00e9s important estar informat per donar un consell professional\u201d. Aix\u00f2 ho va dir N\u00faria Bosch, vocal de Dermofarm\u00e0cia del Col\u00b7legi, nom\u00e9s comen\u00e7ar la confer\u00e8ncia \u201cQueratosis act\u00ednica, una lesi\u00f3 premaligna\u201d, que va tenir lloc [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4805,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[81,70],"class_list":["post-4800","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-dermofarmacia","tag-formacio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u201cEls usuaris, normalment, quan detecten qualsevol s\u00edmptoma a la pell venen a la farm\u00e0cia a consultar i \u00e9s important estar informat per donar un consell professional\u201d. Aix\u00f2 ho va dir N\u00faria Bosch, vocal de Dermofarm\u00e0cia del Col\u00b7legi, nom\u00e9s comen\u00e7ar la confer\u00e8ncia \u201cQueratosis act\u00ednica, una lesi\u00f3 premaligna\u201d, que va tenir lloc [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-01-08T12:40:47+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment\",\"datePublished\":\"2014-01-08T12:40:47+00:00\",\"dateModified\":\"2014-01-08T12:40:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/\"},\"wordCount\":321,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Dermofarm\u00e0cia\",\"Formaci\u00f3\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/\",\"name\":\"Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-01-08T12:40:47+00:00\",\"dateModified\":\"2014-01-08T12:40:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/","og_locale":"ca_ES","og_type":"article","og_title":"Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u201cEls usuaris, normalment, quan detecten qualsevol s\u00edmptoma a la pell venen a la farm\u00e0cia a consultar i \u00e9s important estar informat per donar un consell professional\u201d. Aix\u00f2 ho va dir N\u00faria Bosch, vocal de Dermofarm\u00e0cia del Col\u00b7legi, nom\u00e9s comen\u00e7ar la confer\u00e8ncia \u201cQueratosis act\u00ednica, una lesi\u00f3 premaligna\u201d, que va tenir lloc [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-01-08T12:40:47+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment","datePublished":"2014-01-08T12:40:47+00:00","dateModified":"2014-01-08T12:40:47+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/"},"wordCount":321,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#primaryimage"},"thumbnailUrl":"","keywords":["Dermofarm\u00e0cia","Formaci\u00f3"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/","url":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/","name":"Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-01-08T12:40:47+00:00","dateModified":"2014-01-08T12:40:47+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/08\/queratosis-actinica-una-lesio-premaligna-en-augment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Queratosis act\u00ednica, una lesi\u00f3 premaligna en augment"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u201cEls usuaris, normalment, quan detecten qualsevol s\u00edmptoma a la pell venen a la farm\u00e0cia a consultar i \u00e9s important estar informat per donar un consell professional\u201d. Aix\u00f2 ho va dir N\u00faria Bosch, vocal de Dermofarm\u00e0cia del Col\u00b7legi, nom\u00e9s comen\u00e7ar la confer\u00e8ncia \u201cQueratosis act\u00ednica, una lesi\u00f3 premaligna\u201d, que va tenir lloc [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/4800","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=4800"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/4800\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=4800"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=4800"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=4800"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}